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anBACKGROUND In patients with myocardial infarction (MI), leaﬂet tethering by displaced papillary muscles induces
mitral regurgitation (MR), which doubles mortality. Mitral valves (MVs) are larger in such patients but ﬁbrosis sets in
counterproductively. The investigators previously reported that experimental tethering alone increases mitral valve area
in association with endothelial-to-mesenchymal transition.
OBJECTIVES The aim of this study was to explore the clinically relevant situation of tethering and MI, testing the
hypothesis that ischemic milieu modiﬁes mitral valve adaptation.
METHODS Twenty-three adult sheep were examined. Under cardiopulmonary bypass, the papillary muscle tips in 6
sheep were retracted apically to replicate tethering, short of producing MR (tethered alone). Papillary muscle retraction
was combined with apical MI created by coronary ligation in another 6 sheep (tethered plus MI), and left ventricular
remodeling was limited by external constraint in 5 additional sheep (left ventricular constraint). Six sham-operated sheep
were control subjects. Diastolic mitral valve surface area was quantiﬁed by 3-dimensional echocardiography at baseline
and after 58  5 days, followed by histopathology and ﬂow cytometry of excised leaﬂets.
RESULTS Tethered plus MI leaﬂets were markedly thicker than tethered-alone valves and sham control subjects. Leaﬂet
area also increased signiﬁcantly. Endothelial-to-mesenchymal transition, detected as a-smooth muscle actin-positive
endothelial cells, signiﬁcantly exceeded that in tethered-alone and control valves. Transforming growth factor-b, matrix
metalloproteinase expression, and cellular proliferation were markedly increased. Uniquely, tethering plus MI showed
endothelial activation with vascular adhesion molecule expression, neovascularization, and cells positive for CD45,
considered a hematopoietic cell marker. Tethered plus MI ﬁndings were comparable with external ventricular constraint.
CONCLUSIONS MI altered leaﬂet adaptation, including a proﬁbrotic increase in valvular cell activation, CD45-positive
cells, and matrix turnover. Understanding cellular and molecular mechanisms underlying leaﬂet adaptation and
ﬁbrosis could yield new therapeutic opportunities for reducing ischemic MR. (J Am Coll Cardiol 2016;67:275–87)
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ECM = extracellular matrix
EMT = endothelial-to-
mesenchymal transition
LV = left ventricular
MI = myocardial infarction
MMP = matrix
metalloproteinase
MR = mitral regurgitation
MV = mitral valve
PM = papillary muscle
SMA = smooth muscle actin
TGF = transforming growth
factor
VCAM = vascular cell adhesion
molecule
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276A common complication of ischemicheart disease, mitral regurgitation(MR) doubles mortality and increases
heart failure after myocardial infarction (MI)
(1). Left ventricular (LV) remodeling causes
papillary muscle (PM) displacement that
tethers the mitral valve (MV) leaﬂets and re-
stricts closure (Figures 1A and 1D) (2,3).
As the left ventricle remodels, the surface
area of the stretched MV increases adaptively
to reduce MR (4–6). Ischemic MR remains
common, however, indicating inadequate
leaﬂet compensation (4,5). Valves excised at
the late heart failure stage are stiff and
ﬁbrotic (7–9), further impairing closure by
reducing systolic leaﬂet expansion and the
ﬂexibility needed to bend and seal effec-
tively, as shown by ﬁnite-element analysis(10). Intrinsic MV changes are therefore important for
the full pathogenesis of ischemic MR and its persis-
tence following annuloplasty (11–13).SEE PAGE 288Valve adaptation can be affected not only by me-
chanical stretch but also by the ischemic milieu, with
its known cytokine release (14–16), and by MR tur-
bulence (17,18). We developed a large-animal model
to vary these factors independently, following MV
area noninvasively by 3-dimensional echocardiogra-
phy (Figures 1B, 1C, 1E, and 1F) (4,5,19).
Tethering alone without infarction, induced surgi-
cally by PM traction short of producing MR, increased
MV area and thickness over 2 months (19). The nor-
mally quiescent adult valve endothelium (20) showed
reactivated endothelial-to-mesenchymal transition
(EMT), an early developmental process (21–23).
How the tethered valve is affected by ischemia,
with release of inﬂammatory cytokines and trans-
forming growth factor (TGF)-b (14–16,24–27), is un-
known. We therefore tested the hypothesis that MI
alters adaptation of tethered MVs. A limited apical MI
was used to avoid direct PM displacement by inferior
MI (Figure 1D) (28). MV area changes over 2 months
were explored by excised-leaﬂet molecular histopa-
thology and ﬂow cytometric analysis.e Harvard Clinical and Translational Science Center (National Ce
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Data from 23 adult Dorsett hybrid sheep (weight
>45 kg) were compared: 6 tethered plus MI, 5 tethered
plus MI with LV constraint, 6 tethered alone, and
6 sham-operated control subjects. (The last 2 groups,
previously reported, now have extensive additional
analyses [19]).
The tethered plus MI group required controlled
leaﬂet tethering without MR or leaﬂet disruption,
achieved after left thoracotomy and pericardial cradle
construction under cardiopulmonary bypass. The left
atrium was opened, and suture loops were inserted
via the MV oriﬁce into the exposed PM tips (both
medial PM heads), buttressed by Teﬂon felt pledgets,
and exteriorized to the epicardium overlying the PMs,
pulled through a Dacron anchoring patch, in a model
developed by J. Luis Guerrero. Retracting these su-
tures parallel to the PM axis pulled the PM tips and
leaﬂets apically (19). The heart was restarted and a
limited apical infarct produced by distal left anterior
descending coronary artery ligation, avoiding directly
increased PM tethering from inferior wall bulging (28).
Final suture length was then adjusted in the beating
heart under echocardiographic guidance just short of
producing MR, the sutures were knotted against the
anchoring patch, and the chest was closed.
To limit post-infarction LV remodeling and its
potential effects on leaﬂet tethering and MV adapta-
tion, the tethered plus MI with LV constraint group
required suturing a ﬂexible Prolene surgical mesh
(Ethicon, Somerville, New Jersey) circumferentially
from base to apex around both ventricles after the
creation of the same MV tethering and MI model (3).
This allowed us to explore MV adaptation in an
ischemic milieu with limited post-infarction LV
dilation.
All sheep underwent cardiopulmonary bypass,
with no MI created in the tethered-alone group and
no surgical intervention in the control subjects after
MV and PM exposure.
Animals were cared for 58  5 days and euthanized
after left thoracotomy with echocardiography to
conﬁrm absence of MR and reconstruct MV surface
area. These studies conformed to National Institutesnter for Research Resources and the National Center
L1 TR001102), and ﬁnancial contributions from Har-
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Normal mitral valve (MV) closure with convex leaﬂets toward the left atrium (LA) (A) compared with a tethered MV after papillary muscle (PM) retraction
with concave leaﬂets (D). Echocardiographic views of a sheep heart at baseline (B) and 2 months after PM tethering and apical myocardial infarction
(MI) (E). Limited apical MI results in apical left ventricular remodeling (solid white line) (B vs. E). Tethering of the MV leaﬂets relative to the annulus and
tenting volume are increased (B vs. E; C vs. F, where darker colors indicate increased tenting). PM tethering and apical MI promote leaﬂet adaptation
with increased MV surface area over time (C vs. F). Ao ¼ aorta; LV ¼ left ventricle; MA ¼ mitral annulus.
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277of Health animal care guidelines and had institutional
animal care approval.
IMAGING AND ANALYSIS. Echocardiographic data
were collected using epicardial high-frequency (3.5- to
5-MHz) 2-dimensional and 3-dimensional echocar-
diographic probes (S5 and X3) with an iE33 scanner
(Philips Medical Systems, Andover, Massachusetts).
Three-dimensional volumetric datasets were ECG
gated from 4 to 7 consecutive heartbeats. Full datasets
were acquired in standardized planes at baseline and
before euthanasia. MR absence or grading by
long-axis-view vena contracta and successful MV
leaﬂet tetheringwere assessed in the beating heart just
after PM tethering and MI creation and again prior to
euthanasia. Three-dimensional LV volumes werecalculated from 6 equiangular rotated apical views.
Three-dimensional tenting volume was measured be-
tween the closed leaﬂet atrial surface and the annular
least squares plane (Figures 1C and 1F) (3).
Total MV leaﬂet area was measured at full diastolic
opening to factor out superimposed passive systolic
stretch. (Total leaﬂet area cannot be measured pre-
cisely in systole, because the coapted portions cannot
be optimally resolved). Leaﬂet area was measured in a
blinded fashion using validated custom Omni4D
software (M. D. Handschumacher, Boston, Massa-
chusetts) (Online Appendix) (4,29).
The left atrium was opened and the LV wall
dissected from the anterolateral commissure under
irrigation of pre-cooled sterile phosphate-buffered
saline. Both leaﬂets including chordae were divided
TABLE 1 Echocardiographic Baseline and Euthanasia Measures:
Tethered Plus Myocardial Infarction Model
Baseline Euthanasia p Value
LVEDV, ml 57  7 82  17 0.023
LVESV, ml 24  4 56  13 0.002
LVEF, % 58  3 31  4 <0.001
Posteromedial PM to lateral MA trigone
(systole), mm
32  4 40  3 <0.001
Anterolateral PM to medial MA trigone
(systole), mm
29  3 33  2 0.010
Anterolateral to posteromedial PM
distance (systole), mm
21  4 26  4 0.019
MV leaﬂet area, cm2 13.9  1.8 17.8  2.3 <0.001
Leaﬂet length A2, mm 15.4  1.8 18.6  2.3 0.003
Leaﬂet length P2, mm 13.4  1.8 16.4  1.6 0.010
Annular area (diastole), cm2 8.66  1.44 11.49  1.11 0.002
Annular area (systole), cm2 7.98  1.17 10.12  1.28 0.006
Early systolic tenting volume, cm3 1.76  0.52 3.32  0.95 0.017
Late systolic tenting volume, cm3 0.85  0.19 2.03  0.69 0.009
Values are mean  SD.
A2 ¼ anterior mitral valve leaﬂet, middle scallop; LVEDV ¼ left ventricular end-diastolic vol-
ume; LVEF ¼ left ventricular ejection fraction; LVESV ¼ left ventricular end-systolic volume;
MA ¼ mitral annulus; MV ¼ mitral valve; PM ¼ papillary muscle; P2 ¼ posterior mitral valve
leaﬂet, middle scallop.
TABLE 2 Echocardio
MV leaﬂet area increas
MV leaﬂet length incre
MV leaﬂet thickness, m
VECs coexpressing a-S
CD45-positive cells/HP
Ki67-positive cells/HPF
Microvessels/HPF
Values are mean  SD or
†p < 0.05, tethered only ve
LV constraint.
HPF ¼ high-powered ﬁel
muscle actin; VEC ¼ valvu
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278for histopathology (frozen in optimal cutting tem-
perature compound at 80C) (Online Appendix) and
cell isolation and ﬂow cytometry (transported in
pre-cooled physiological collecting medium) (Online
Appendix).
Microscopy was used to measure leaﬂet thickness
in the 10 thickest areas across the leaﬂet midportion
and anterior and posterior strut chordal thickness.
STATISTICAL ANALYSIS. One-way analysis of variance
with post-hoc contrast analysis and Tukey-Kramer
test were used when appropriate to compare multiple
groups of interest. Paired Student t tests were used to
compare baseline and euthanasia results withingraphic, Histological, and Flow Cytometric Results
Control
Tethered
Alone
Tethered
Plus MI
Tethered Plus MI
LV Constraint
e, % 1  4 17  10* 28  6‡ 18  4
ase, % 0.5  2.9 10.9  6.8* 22.3  7.5‡ 10  7.7
m 0.42  0.14 1.18  0.14*† 1.61  0.19 1.57  0.22
MA, % 7  4
6 (4–11)
40  19*
39 (21–59)
62  16
61 (51–73)
52  12
53 (44–57)
F 3  1
3 (2–4)
2  3*†
2 (0–5)
25  4
26 (22–29)
22  3
20 (19–24)
5  1
5 (4–5)
19  5*
19 (15–22)
50  13
51 (42–55)
35  11
31 (29–45)
1  2
0 (0–3)
1  1*†
1 (0–1)
5  2
5 (5–6)
4  3
4 (3–6)
median (interquartile range). *p < 0.05, tethered only versus tethered plus MI.
rsus tethered plus MI LV constraint. ‡p < 0.05, tetheredþMI versus tethered plus MI
d; LV ¼ left ventricular; MI ¼myocardial infarction; MV ¼mitral valve; SMA ¼ smooth
lar endothelial cell.animals. Data are summarized as mean  SD for
continuous variables and as medians with percentiles
as appropriate. Statistical signiﬁcance was set at
p < 0.05 (2-sided).
RESULTS
The tethered plus MI group sheep all had apical MI
with decreased LV ejection fraction at euthanasia
(from 58  3% to 31  4%, p < 0.001) and PM retrac-
tion with tented mitral leaﬂets (baseline vs. eutha-
nasia, Figure 1B vs. 1E; Table 1 tenting volumes).
Diastolic and systolic mitral annular area increased
from baseline to euthanasia (Table 1); MR remained
trace after model creation and before euthanasia
(vena contracta: 0.12  0.1 cm vs. 0.13  0.1 cm;
p ¼ 0.771).
In tethered plus MI sheep, total leaﬂet area
consistently increased by 3.9  0.9 cm2 (28  6%)
from 13.9  1.8 cm2 to 17.8  2.3 cm2 over 2 months
(p < 0.001), as did leaﬂet length (Table 1). The leaﬂet
area increase was greater than in animals with teth-
ering alone or sham surgery (28  6% vs. 17  10% vs.
1  4%, respectively, p < 0.001). Tethered plus MI
MVs were thicker than tethered-alone MVs and 3.8
times thicker than control MVs (1.61  0.19 mm vs.
1.18  0.14 mm vs. 0.42  14 mm, p < 0.001) (Table 2,
Figure 2A). Increased thickness and disrupted matrix
were apparent in adjacent sections stained with
Masson and picrosirius red (Figures 2A and 2B).
Increased leaﬂet size and opacity, consistent with
thickening, were visible at euthanasia (Figures 2C and
2D). In the tethered plus MI sheep, although diastolic
annular area increased from baseline to euthanasia by
an average of 34%, there was no signiﬁcant change in
the ratio of leaﬂet to annular area as a measure of
adaptation (1.61  0.07 vs. 1.54  0.09, p ¼ 0.331),
comparable with the ratio in patients with tethered
versus normal leaﬂets (4).
CELLULAR EXPRESSION, RECRUITMENT, AND
PROLIFERATION. Normal endothelial cells express
CD31 but not a–smooth muscle actin (SMA)
(Figure 3A). Tethering only, as previously reported,
induces a-SMA expression in the endothelium on the
MV’s atrial side, indicating endothelial activation and
EMT, with mild interstitial penetration of a-SMA-
positive cells (Figure 3A) (19). In contrast, tethered
plus MI sheep showed exuberant a-SMA expression
along the MV’s atrial side, extending deep into the
interstitium (Figure 3A, right-hand panels). Expres-
sion of the endothelial cell-surface marker CD31 was
diminished with tethering plus MI, further indicating
EMT with loss of cell-cell contacts, allowing
FIGURE 2 Mitral Leaﬂet Thickness and Surface Area
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(A) Leaﬂet tethering alone and with myocardial infarction (MI) increases leaﬂet thickness via expansion of spongiosa layer (arrows), even when controlled for left
ventricular (LV) volume by constraint in tethered plus MI sheep (Masson, top; picrosirius red, bottom). (B) Quantitative comparison of leaﬂet thickness in all groups.
(C) Tethered plus MI mitral valve (MV) leaﬂets show increased area and opacity consistent with increased thickness (centimeters). (D) Quantitative comparison of
leaﬂet area increase in all groups. PM ¼ papillary muscle.
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279interstitial migration (Figure 3A, third lower panel).
Weak CD31 staining could be seen in isolated cells
within the interstitium (Figure 3A, inset), consistent
with penetration of cells undergoing EMT. Flow
cytometry of cells digested from the leaﬂets similarly
showed an increased percent of endothelial cells
(CD31 positive) coexpressing a-SMA in the tethered
plus MI MVs more than in tethered-alone MVs and
control MVs (62  16% vs. 40  19% vs. 7  4%, p < 0.
001) (Figure 3B, Online Figure 1, Table 2).
Vascular cell adhesion molecule (VCAM)-1, a
leukocyte adhesion molecule marking endothelial
activation, was consistently expressed in the endo-
thelium of tethered plus MI valves (Figure 4A, upper
panels, and Figure 4B, red staining absent in tethered-
alone MVs). TGF-b expression, not detected in normal
adult valves and only mildly evident in tethered-alone MVs, was prominent on the atrial side of teth-
ered plus MI MVs extending interstitially (Figure 4A,
lower panels, and Figure 4B). Figure 4B shows adja-
cent sections of a tethered plus MI valve stained for
a-SMA, TGF-b, collagen accumulation, and VCAM-1;
all but VCAM-1 show endothelial and subendothelial
colocalization.
Increased VCAM-1 along the endothelium could
increase cellular recruitment into the valve. We
therefore evaluated MV sections for cells expressing
the hematopoietic marker CD45. Tethered plus MI
MVs contained signiﬁcantly more CD45-positive cells,
uncommon in tethered-alone MVs and control MVs
(Figures 5A and 5B). Cell proliferation detected by
Ki67 immunostaining was also strongly increased in
both endothelial and interstitial cells of tethered
plus MI MVs (Figures 5C and 5D). CD45- and Ki67-
FIGURE 3 Mitral Valve EMT
90
80
70
60
50
40
30
20
10
0
%
EC
 U
nd
er
go
in
g 
EM
T
Control Tethered Tethered+MI Tethered+MI
LV constraint
p=0.213
p=0.013 p=0.250
Control Tethered Tethered+MI
Tethered+MI
LV ConstraintA B
(A) Staining for interstitial marker a–smooth muscle actin (SMA) along the CD31-positive endothelium shows increasing extension of a-SMA-positive cells
into the interstitium (asterisks) for the study groups with tethered mitral valves; occasional CD31-positive staining was seen in the interstitium.
(B) Quantitative analysis of endothelial cells (ECs) detected by ﬂow cytometry that are also a-SMA-positive, indicating endothelial-to-mesenchymal
transformation (EMT), and expressed as percentage of total CD31-positive cells. Abbreviations as in Figure 1.
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280positive cells were predominantly in the atrialis and
spongiosa.
INGROWTH AND REMODELING. Normal cardiac
valves are largely avascular. Neovascularization is
common in degenerative disease and potentially fa-
cilitates inﬂammation and cell recruitment. Tethered
plus MI valves showed more microvessels in their
midportions than tethered-alone and control MVs
(Figures 5C and 5D).
Overexpression of matrix-degrading enzymes by
activated myoﬁbroblasts occurs in human myxoma-
tous degeneration (30). The present study demon-
strated abundant expression of proteolytic matrix
metalloproteinase (MMP)–2 and MMP-9, particularly
in the spongiosa (Figure 6), suggesting excessive
collagen degradation and remodeling in tethered plus
MI MVs. Picrosirius red collagen staining (Figure 2A,
lower panels) conﬁrmed these results, demonstrating
poorly organized collagen in the enlarged spongiosa,
also evident by Masson staining (Figure 2A, upper
panels). Online Figure 2 shows heterogeneous areas
of increased and reduced subatrial collagen (compare
the focal collagen deposition in Figure 4B, lower left).
Online Figure 3 indicates subatrial elastin loss in
tethered plus MI valves.
Anterior and posterior strut chordae in the teth-
ered plus MI sheep were thicker compared with
tethered-alone and sham surgery animals (2.2 
1.0 mm vs. 1.2  0.1 mm vs. 0.9  0.1 mm, p < 0.05)
(Figures 7A to 7C). Figures 7E and 7F show signiﬁcant
a-SMA expression and CD45-positive cells in tethered
plus MI chordae.
LV CONSTRAINT. Three-dimensional echocardio-
graphic analyses (Online Appendix) showed thattethered plus MI sheep had increased LV volumes and
tethering distances at euthanasia compared with
tethered-alone sheep. To explore whether the MV
changes also occur without such increases in volume,
we studied 5 additional tethered plus MI sheep
in which LV volumes were limited by external con-
straint. With this constraint, LV volumes and teth-
ering distances at euthanasia were comparable with
those with tethering alone and signiﬁcantly less
than in tethered plus MI sheep without constraint
(Online Appendix, Online Figure 4). Despite this
reduction in LV expansion and tethering, MV changes
were qualitatively and quantitatively comparable
with those in tethered plus MI sheep without
constraint, including consistently and prominently
increased leaﬂet thickness (Figures 2A and 2B), EMT
with extensive subendothelial a-SMA staining
(Figures 3A and 3B), TGF-b and endothelial VCAM-1
staining (Figure 4A), CD45-positive cells (Figures 5A
and 5B), Ki67-positive cells (Figures 5C and 5D),
microvasculature ingrowth (Figures 5C and 5D), and
MMP-2/MMP-9 (Figure 6). Leaﬂet area increased less
in the constrained tethered plus MI sheep, consistent
with the smaller left ventricle (Figure 2D) and poten-
tially corresponding to the mildly but not signiﬁ-
cantly lower percentage of endothelial cells
undergoing EMT and Ki67-positive cells (Figures 3B
and 5D). Chordal thickness, EMT, and CD45-positive
cells were also comparable (Figure 7).
DISCUSSION
This study goes beyond prior in vivo observations
that mechanical MV tethering reactivates EMT, an
embryonic growth process, increasing both leaﬂet
FIGURE 4 VCAM-1 and TGF-b Staining
(A) Endothelial vascular cell adhesion molecule (VCAM)-1 staining (red, upper panel) only in the tethered plus myocardial infarction (MI) and
tethered plus MI left ventricular (LV) constraint valves. Increased interstitial transforming growth factor (TGF)-b staining in tethered plus MI
and tethered plus MI LV constraint valves versus tethered-alone valves (lower panels). (B) Adjacent sections of tethered plus MI mitral
valve showing colocalization of a-SMA (a), TGF-b (b), ﬁbrosis (collagen accumulation) (c, Masson) and endothelial cell activation
(VCAM-1, arrows, d).
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281area and thickness (19,21–23). Stretch induces
valve expression of TGF-b (31), an EMT promoter
(32). TGF-b was expressed but not strongly with
tethering alone, suggesting that mild TGF-b induction
may sufﬁce to promote leaﬂet growth or that other
signals may also activate EMT. These ﬁndings indi-
cate that adult valves, normally quiescent (20), can
respond to stress and altered ventricular geometry
(19,20,23), as seen with their enlargement in the
remodeled ventricles of patients with aortic insufﬁ-
ciency (33).
When apical MI is added to mechanical tethering,
EMT and TGF-b are markedly augmented, with
prominently increased cellular proliferation andleaﬂet and chordal thickness. Additional changes,
previously unrecognized post-MI, occur that are not
evident with tethering alone: endothelial activation,
indicated by VCAM-1 expression; the presence of
CD45-positive cells; neovascularization; and extra-
cellular matrix (ECM) remodeling with increased
MMP expression (Central Illustration).
As expected, tethering is mildly augmented by
MI-induced LV remodeling, and this may contribute
to changes in the MV. However, MI-induced valve
changes persist when external constraint limits
LV remodeling and reduces tethering distances.
Furthermore, tethered-alone and tethered plus MI
valves are different not only in degree of EMT,
FIGURE 5 Mitral Valve CD45-Positive Cells, Cell Proliferation, and Microvessels
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(A) CD45-positive cells (arrows) in tethered plus myocardial infarction (MI) and tethered plus MI left ventricular (LV) constraint valves are shown (bottom panels: high
magniﬁcation of representative ﬁelds) and analyzed (B). (C) Increased cellular proliferation (Ki67, upper panels, asterisks) and microvessels (lower panels) are greatest
in tethered plus MI and tethered plus MI LV constraint valves, also seen by quantitative analysis (D). HPF ¼ high-powered ﬁeld.
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282thickness, and TGF-b expression but also in nature
of changes, with endothelial VCAM-1 activation,
accumulation of CD45-positive cells, and neovas-
cularization. The post-MI effects on MV adaptation
therefore do not appear to depend solely on
LV remodeling, although it seems reasonable that
they may increase with LV remodeling-induced
tethering.Understanding the nature and mechanisms of
post-MI MV changes can potentially provide insights
into clinically important questions: Why is leaﬂet
adaptation frequently inadequate to prevent MR
post-MI, unlike adequate adaptation in aortic insuf-
ﬁciency (4,5,33,34)? Why does deleterious leaﬂet
stiffening occur, impairing coaptation (8,10)? Why do
current therapies have limitations (11–13)? And what
FIGURE 6 Mitral Valve Matrix MMP Staining
Matrix metalloproteinase (MMP-2 and MMP-9) staining is greatest in tethered plus myocardial infarction (MI) and tethered plus MI left
ventricular (LV) constraint valves.
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283therapies might help? Several possible mechanisms
inﬂuencing MV remodeling and growth active post-
MI are suggested by our observations.
For example, TGF-b, proﬁbrotic in many organs, is
overexpressed in the tethered plus MI valves and
seen in areas of increased collagen deposition
(Figures 4A and 4B). Although TGF-b is a key stimulus
for EMT and growth in the developing valve (21–23), it
could drive valve ﬁbrosis by activating valvularFIGURE 7 Chordal Changes
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Tethered+MI Chordae
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(A–D) Chordal thickness is greatest in the tethered plus myocardial infar
a–Smooth muscle actin (SMA)–positive (E,G) and CD45-positive (F,H) ce
in tethered plus MI and tethered plus MI LV constraint chords, suggestiinterstitial cells to become contractile a-SMA-positive
myoﬁbroblasts that secrete, compact, and remodel
the extracellular matrix (24–27,35,36). The ﬁbrogenic
effects of TGF-b might be ampliﬁed by its activation
of angiotensin type–1 receptors (26) that in turn
would increase TGF-b expression.
TGF-b as a compensatory response to stretch may
therefore become counterproductive post-MI (30),
causing excessive EMT as a substrate for valve ﬁbrosis,ae
Tethered+MI LV constraint Chordae
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D
H
ction (MI) and tethered plus MI left ventricular (LV) constraint sheep.
lls are seen near the chordal endothelium and within the interstitium
ng chordal endothelial-to-mesenchymal transition.
CENTRAL ILLUSTRATION Ischemia Alters Mitral Valve Adaptation: Cellular and Molecular Events in the Tethered Mitral Valve With
Myocardial Infarction Compared With Tethered Valve Alone and Impact on Valve Function
A
B
Dal-Bianco, J.P. et al. J Am Coll Cardiol. 2016; 67(3):275–87.
(A) Comparedwith tethered-alone leaﬂets, the endothelium of tethered plusmyocardial infarction (MI)mitral valves (MVs) undergoes excessive endothelial-to-mesenchymal
transition (EMT) and is positive for vascular cell adhesion molecule (VCAM)-1, indicating endothelial activation; the interstitium shows abundant CD45-positive cells and
microvessels that may act as additional ports of cellular entry. Extracellular matrix remodeling is markedly up-regulated in tethered plus MI leaﬂets (increased transforming
growth factor [TGF]–b andmatrixmetalloproteinases [MMPs]), alongwith a hyperproliferative increase inKi67-positive cells. (B)Leaﬂet area increasehas thepotential to adapt
to post-MI left ventricular (LV) remodeling and tethering and prevent mitral regurgitation (MR); inadequate area increase, with potential retraction and thickening of the
tethered leaﬂets and chordae by induced a-smoothmuscle actin–positivemyoﬁbroblasts, can augmentMR followingMI. EC¼ endothelial cells; VIC¼ valvular interstitial cell.
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284stiffening, and regurgitation (8–10,35). TGF-bmay fur-
ther lead to myoﬁbroblast-induced matrix contraction
(25) that can limit the ability of the valve to increase
its area, possibly explaining the relative deﬁciency
in valve area post-MI despite increased ventricular
size (Central Illustration). TGF-b can also drive the
increased chordal EMT and ﬁbrotic thickening seen in
the tethered plus MI valves (Figure 7), further restrict-
ing leaﬂet closure and increasing regurgitation.TGF-b may originate from the stretched valve
itself; TGF-b is also markedly increased in ischemic
myocardium and released into the cardiac extracel-
lular ﬂuid (24). Conceivably, post-MI neurohumoral
activation of proﬁbrotic angiotensin II and aldoste-
rone may promote ﬁbrosis, synergistically with TGF-b.
Activation of the endothelial leukocyte adhesion
molecule VCAM-1, seen only in the tethered plus MI
valves (Figures 4A and 4B), suggests the presence of
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285inﬂammatory cytokines (37). Myocardial ischemia
and infarction strongly induce release of proin-
ﬂammatory cytokines such as tumor necrosis factor–a,
interleukin-1b, and interleukin-6 from infarct zones
and, later in ventricular remodeling, from non-
infarcted myocardium (14–16). Endothelial activation
by these cytokines recruits circulating cells into the
infarct (37). Cytokines promote ECM remodeling with
MMP activation, interstitial ﬁbrosis, and collagen
deposition in infarcted and remote zones (38).
Infarct-induced cytokines may likewise explain the
endothelial activation (VCAM-1 expression) seen
in tethered plus MI valves, contributing to their
matrix remodeling and abundant MMP expression
(Figure 6).
An unexpected ﬁnding was the prominence of cells
positive for CD45, considered a pan-hematopoietic
cell marker, in the tethered plus MI leaﬂets and
chordae (Figures 5A, 5B, and 7). Although these cells
require further characterization, one hypothesis
consistent with other ﬁndings is that they are ﬁbro-
cytes, circulating bone marrow–derived cells that
enter sites of injury and inﬂammation and adopt an
a-SMA-positive myoﬁbroblast phenotype (38–41).
Fibrocytes, beneﬁcial in normal wound healing and
compaction, produce stiffened, sclerotic tissue in
pulmonary ﬁbrosis, asthma, and ﬁbrosing renal and
cutaneous diseases (39–41). They are also recruited to
ischemic myocardium, where their inhibition report-
edly reduces cardiac remodeling (42).
An equilibrium normally exists between circulating
bone marrow–derived cells and the cardiac valves
(43); this may be altered by activating cell adhesion
molecules (37), as in the tethered plus MI valves.
Marrow-derived cell recruitment is a ubiquitous
response to diverse vascular and valvular injuries.
Tanaka et al. (44) showed that marrow-derived cells
recruited to the aortic valve display a mesenchymal
phenotype in hypercholesterolemic mice.
At least a subset of the observed CD45-positive cells
may therefore represent ﬁbrocytes recruited into the
stressed post-MI valve, inﬂuenced by VCAM-1 activa-
tion and TGF-b (38–40,45), which promotes their
differentiation to myoﬁbroblasts (46). Activated
ﬁbrocyte-derived myoﬁbroblasts secrete additional
TGF-b (39–41), proinﬂammatory cytokines, MMPs, and
ECM components, reinforcing post-MI valve changes.
CLINICAL AND THERAPEUTIC IMPLICATIONS. The
observations in this study suggest post-MI transition
from adaptive MV enlargement to maladaptive limi-
tation of enlargement and counterproductive stiff-
ening (15,26). TGF-b overexpression, exuberant EMT
as substrate for ﬁbrosis, and endothelial activation
with circulating cell recruitment in the ﬁbrocytehypothesis can promote ﬁbrosis and matrix compac-
tion (Central Illustration).
Understanding these mechanisms has potential
therapeutic implications, with the long-range goal of
augmenting MV area and preserving leaﬂet ﬂexibility
to reduce ischemic MR. TGF-b pathways can be
inhibited, for example, using angiotensin type–1 re-
ceptor blockers as TGF-b antagonists to limit tissue
growth in a Marfan mouse model (47). Pharmacolog-
ical modiﬁcation may require a speciﬁc time window
to permit early EMT but prevent later ﬁbrosis (24).
STUDY LIMITATIONS AND FUTURE DIRECTIONS. We
compared changes when MI was superimposed on
mechanical tethering without MR. Further work will
be needed to explore the effects of MI alone, MR tur-
bulence, and TGF-b blockade. MR alone increases MV
collagen deposition, MMPs, and circulating tumor
necrosis factor–a (18,48) but down-regulates myocar-
dial noncollagen ECM components and TGF-b (49); MR
combined with tethering can be tested in inferior MI.
Inferior MI increases valve area, but insufﬁciently to
prevent MR (5). Whether CD45-positive cells are
beneﬁcial or adverse needs to be explored (43,46), as
do the roles of VCAM-1 and TGF-b in cell recruitment.
To determine why cellular changes (EMT, VCAM-1)
mainly affect the atrial side of the MV requires testing
biological differences between atrial and ventricular
endothelium, compounding the higher atrialis radius
of curvature and stress. Longitudinal studies are
needed to explore clinically important questions of
how the MV changes over time, why leaﬂet adapta-
tion is frequently inadequate to prevent MR, and how
this can be improved.
CONCLUSIONS
MV adaptation to mechanical stretch created by PM
tethering with concomitant MI is different in nature
and extent than with PM tethering alone, including
exuberant EMT, cellular proliferation, TGF-b over-
expression, endothelial activation, accumulation of
CD45-positive cells, neovascularization, and matrix
remodeling. Potential explanations based on syner-
gistic stretch- and MI-induced pathways involve
TGF-b, proinﬂammatory cytokines, and recruited
ﬁbrocytes. Understanding these mechanisms could
lead to new therapeutic opportunities to increase
leaﬂet area and ﬂexibility and preserve coaptation.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: A teth-
ered MV has the potential for compensatory leaﬂet
adaptation. In patients with volume overload from
chronic aortic insufﬁciency, MV growth matches ventric-
ular dilation, and MR is rare. With comparable ventricular
dilation after MI, however, MV growth is often insufﬁ-
cient, and the leaﬂets become thick and ﬁbrosed; MR is
frequent, and heart failure and mortality risks are
doubled.
TRANSLATIONAL OUTLOOK: Future research should
seek to identify the cellular pathways through which
post-MI tethering promotes MV leaﬂet and chordal
growth so that therapeutic strategies can be developed
on the basis of these adaptive mechanisms.
Dal-Bianco et al. J A C C V O L . 6 7 , N O . 3 , 2 0 1 6
Ischemia Alters Mitral Valve Adaptation J A N U A R Y 2 6 , 2 0 1 6 : 2 7 5 – 8 7
286RE F E RENCE S1. Grigioni F, Enriquez-Sarano M, Zehr KJ, et al.
Ischemic mitral regurgitation: long-term outcome
and prognostic implications with quantitative
Doppler assessment. Circulation2001;103:1759–64.
2. Kono T, Sabbah HN, Rosman H, et al. Left
ventricular shape is the primary determinant of
functional mitral regurgitation in heart failure.
J Am Coll Cardiol 1992;20:1594–8.
3. Otsuji Y, Handschumacher MD,
Schwammenthal E, et al. Insights from three-
dimensional echocardiography into the mecha-
nism of functional mitral regurgitation: direct
in vivo demonstration of altered leaﬂet tethering
geometry. Circulation 1997;96:1999–2008.
4. Chaput M, Handschumacher MD, Tournoux F,
et al. Mitral leaﬂet adaptation to ventricular
remodeling: occurrence and adequacy in patients
with functional mitral regurgitation. Circulation
2008;118:845–52.
5. Chaput M, Handschumacher MD, Guerrero JL,
et al. Mitral leaﬂet adaptation to ventricular
remodeling: prospective changes in a model of
ischemic mitral regurgitation. Circulation 2009;
120 11 Suppl:S99–103.
6. Rausch MK, Tibayan FA, Miller DC, Kuhl E. Ev-
idence of adaptive mitral leaﬂet growth. J Mech
Behav Biomed Mater 2012;15:208–17.
7. Quick DW, Kunzelman KS, Kneebone JM,
Cochran RP. Collagen synthesis is upregulated in
mitral valves subjected to altered stress. ASAIO J
1997;43:181–6.
8. Grande-Allen KJ, Barber JE, Klatka KM, et al.
Mitral valve stiffening in end-stage heart failure:
evidence of an organic contribution to functional
mitral regurgitation. J Thorac Cardiovasc Surg
2005;130:783–90.
9. Grande-Allen KJ, Borowski AG, Troughton RW,
et al. Apparently normal mitral valves in patients
with heart failure demonstrate biochemical and
structural derangements: an extracellular matrix
and echocardiographic study. J Am Coll Cardiol
2005;45:54–61.
10. Kunzelman KS, Quick DW, Cochran RP. Altered
collagen concentration in mitral valve leaﬂets:biochemical and ﬁnite element analysis. Ann
Thorac Surg 1998;66:S198–205.
11. Acker MA, Parides MK, Perrault LP, et al.
Mitral-valve repair versus replacement for severe
ischemic mitral regurgitation. N Engl J Med 2014;
370:23–32.
12. Hung J, Papakostas L, Tahta SA, et al. Mech-
anism of recurrent ischemic mitral regurgitation
after annuloplasty: continued LV remodeling as a
moving target. Circulation 2004;110:II85–90.
13. McGee EC, Gillinov AM, Blackstone EH, et al.
Recurrent mitral regurgitation after annuloplasty
for functional ischemic mitral regurgitation.
J Thorac Cardiovasc Surg 2004;128:916–24.
14. Frangogiannis NG, Smith CW, Entman ML. The
inﬂammatory response in myocardial infarction.
Cardiovasc Res 2002;53:31–47.
15. Mann DL. Stress-activated cytokines and the
heart: from adaptation to maladaptation. Annu
Rev Physiol 2003;65:81–101.
16. Nian M, Lee P, Khaper N, Liu P. Inﬂammatory
cytokines and postmyocardial infarction remodel-
ing. Circ Res 2004;94:1543–53.
17. Fornes P, Heudes D, Fuzellier JF, et al. Corre-
lation between clinical and histologic patterns of
degenerative mitral valve insufﬁciency: a histo-
morphometric study of 130 excised segments.
Cardiovasc Pathol 1999;8:81–92.
18. Stephens EH, Nguyen TC, Itoh A, et al. The
effects of mitral regurgitation alone are sufﬁcient
for leaﬂet remodeling. Circulation 2008;118 14
Suppl:S243–9.
19. Dal-Bianco JP, Aikawa E, Bischoff J, et al. Active
adaptation of the tethered mitral valve: insights
into a compensatory mechanism for functional
mitral regurgitation. Circulation 2009;120:334–42.
20. Aikawa E, Whittaker P, Farber M, et al. Human
semilunar cardiac valve remodeling by activated
cells from fetus to adult: implications for post-
natal adaptation, pathology, and tissue engineer-
ing. Circulation 2006;113:1344–52.
21. Armstrong EJ, Bischoff J. Heart valve devel-
opment: endothelial cell signaling and differenti-
ation. Circ Res 2004;95:459–70.22. Combs MD, Yutzey KE. Heart valve develop-
ment: regulatory networks in development and
disease. Circ Res 2009;105:408–21.
23. Markwald RR, Norris RA, Moreno-Rodriguez R,
Levine RA. Developmental basis of adult cardio-
vascular diseases: valvular heart diseases. Ann N Y
Acad Sci 2010;1188:177–83.
24. Bujak M, Frangogiannis NG. The role of TGF-
beta signaling in myocardial infarction and car-
diac remodeling. Cardiovasc Res 2007;74:184–95.
25. Walker GA, Masters KS, Shah DN, et al.
Valvular myoﬁbroblast activation by transforming
growth factor-beta: implications for pathological
extracellular matrix remodeling in heart valve
disease. Circ Res 2004;95:253–60.
26. Rosenkranz S. TGF-beta1 and angiotensin
networking in cardiac remodeling. Cardiovasc Res
2004;63:423–32.
27. Leask A. Potential therapeutic targets for
cardiac ﬁbrosis: TGFbeta, angiotensin, endothelin,
CCN2, and PDGF, partners in ﬁbroblast activation.
Circ Res 2010;106:1675–80.
28. Gorman JH III, Gorman RC, Plappert T, et al.
Infarct size and location determine development
of mitral regurgitation in the sheep model.
J Thorac Cardiovasc Surg 1998;115:615–22.
29. Beaudoin J, Thai WE, Wai B, et al. Assessment
of mitral valve adaptation with gated cardiac
computed tomography: validation with three-
dimensional echocardiography and mechanistic
insight to functional mitral regurgitation. Circ
Cardiovasc Imaging 2013;6:784–9.
30. Rabkin E, Aikawa M, Stone JR, et al. Activated
interstitial myoﬁbroblasts express catabolic en-
zymes and mediate matrix remodeling in myxo-
matous heart valves. Circulation 2001;104:
2525–32.
31. Ku CH, Johnson PH, Batten P, et al. Collagen
synthesis by mesenchymal stem cells and aortic
valve interstitial cells in response to mechanical
stretch. Cardiovasc Res 2006;71:548–56.
32. Person AD, Klewer SE, Runyan RB. Cell biology
of cardiac cushion development. Int Rev Cytol
2005;243:287–335.
J A C C V O L . 6 7 , N O . 3 , 2 0 1 6 Dal-Bianco et al.
J A N U A R Y 2 6 , 2 0 1 6 : 2 7 5 – 8 7 Ischemia Alters Mitral Valve Adaptation
28733. Beaudoin J, Handschumacher MD, Zeng X,
et al. Mitral valve enlargement in chronic aortic
regurgitation as a compensatory mechanism to
prevent functional mitral regurgitation in the
dilated left ventricle. J Am Coll Cardiol 2013;61:
1809–16.
34. Saito K, Okura H, Watanabe N, et al. Inﬂuence
of chronic tethering of the mitral valve on mitral
leaﬂet size and coaptation in functional mitral
regurgitation. J Am Coll Cardiol Img 2012;5:
337–45.
35. Zeisberg EM, Tarnavski O, Zeisberg M, et al.
Endothelial-to-mesenchymal transition con-
tributes to cardiac ﬁbrosis. Nat Med 2007;13:
952–61.
36. Liu AC, Gotlieb AI. Transforming growth
factor-beta regulates in vitro heart valve repair by
activated valve interstitial cells. Am J Pathol
2008;173:1275–85.
37. Kakio T, Matsumori A, Ono K, Ito H,
Matsushima K, Sasayama S. Roles and relationship
of macrophages and monocyte chemotactic and
activating factor/monocyte chemoattractant
protein-1 in the ischemic and reperfused rat heart.
Lab Invest 2000;80:1127–36.
38. Wynn TA. Cellular and molecular mechanisms
of ﬁbrosis. J Pathol 2008;214:199–210.39. Herzog EL, Bucala R. Fibrocytes in health and
disease. Exp Hematol 2010;38:548–56.
40. Keeley EC, Mehrad B, Strieter RM. Fibrocytes:
bringing new insights into mechanisms of inﬂam-
mation and ﬁbrosis. Int J Biochem Cell Biol 2010;
42:535–42.
41. Hong KM, Belperio JA, Keane MP, et al. Dif-
ferentiation of human circulating ﬁbrocytes as
mediated by transforming growth factor-beta and
peroxisome proliferator-activated receptor
gamma. J Biol Chem 2007;282:22910–20.
42. Haudek SB, Xia Y, Huebener P, et al. Bone
marrow-derived ﬁbroblast precursors mediate
ischemic cardiomyopathy in mice. Proc Natl Acad
Sci U S A 2006;103:18284–9.
43. Visconti RP, Ebihara Y, LaRue AC, et al. An
in vivo analysis of hematopoietic stem cell po-
tential: hematopoietic origin of cardiac valve
interstitial cells. Circ Res 2006;98:690–6.
44. TanakaK, SataM,FukudaD,etal.Age-associated
aortic stenosis in apolipoprotein E-deﬁcient mice.
J Am Coll Cardiol 2005;46:134–41.
45. Wahl SM, Hunt DA, Wakeﬁeld LM, et al.
Transforming growth factor type beta induces
monocyte chemotaxis and growth factor produc-
tion. Proc Natl Acad Sci U S A 1987;84:5788–92.46. Deb A, Wang SH, Skelding K, et al. Bone
marrow-derived myoﬁbroblasts are present in
adult human heart valves. J Heart Valve Dis 2005;
14:674–8.
47. Ng CM, Cheng A, Myers LA, et al. TGF-beta-
dependent pathogenesis of mitral valve prolapse
in a mouse model of Marfan syndrome. J Clin
Invest 2004;114:1586–92.
48. Oral H, Sivasubramanian N, Dyke DB, et al.
Myocardial proinﬂammatory cytokineexpressionand
left ventricular remodeling in patients with chronic
mitral regurgitation. Circulation 2003;107:831–7.
49. Zheng J, Chen Y, Pat B, et al. Microarray iden-
tiﬁes extensive downregulation of noncollagen
extracellular matrix and proﬁbrotic growth factor
genes in chronic isolated mitral regurgitation in the
dog. Circulation 2009;119:2086–95.
KEY WORDS echocardiography,
endothelial-to-mesenchymal transition,
inﬂammation, mitral regurgitation, papillary
muscle
APPENDIX For a supplemental methods and
results section as well as ﬁgures, please see the
online version of this article.
